Clinical Trial Update: PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI [NA]

View source ↗

Summary

A clinical trial is evaluating adding a PCSK9 inhibitor to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Hyperlipidemia

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Acute Coronary Syndrome, Hyperlipidemias | NA | Status: RECRUITING